Online trial investigator result meetings - what about the investigators’ feedback?
Laura Lassen
Posted by Laura Lassen
January 22, 2021

Online trial investigator result meetings - what about the investigators’ feedback?

Following the outbreak of the COVID-19 pandemic, we now see that investigator result meetings have changed their format to online interaction...

Informing trial patients on the clinical trial results
Laura Lassen
Posted by Laura Lassen
December 30, 2020

Are you properly informing your trial patients on the clinical trial results?

The importance of keeping your trial patients well-informed. True patient-centricity is not only obtaining input from trial patients – it also involves ...

Patient and Public Involvement (PPI)
Laura Lassen
Posted by Laura Lassen
December 18, 2020

Initiatives facilitating the advancement of Patient and Public Involvement in drug development

Patient and Public Involvement (PPI) can improve clinical research success. PPI is defined as research that is carried out with or by patients and those who have experience of a condition...

Patient feedback
Laura Lassen
Posted by Laura Lassen
December 11, 2020

Consequences of not listening to the patients in clinical trials

Are you overlooking patient feedback on your investigational drug? Interestingly, the pharmaceutical industry is one of the few industries where...

Patient preferences as input to drug development
Laura Lassen
Posted by Laura Lassen
December 4, 2020

Patient preferences as input to medical product decision making

PREFER’s patient input to decision making under evaluation by EMA and EUnetHTA. At Clinigma®, we are always happy to follow the development of projects promoting patient engagement...

Feedback from investigators and study nurses
Laura Lassen
Posted by Laura Lassen
November 27, 2020

Have you considered improving the feedback from investigators and study nurses in your clinical trials?

The importance of interviewing investigators and study nurses. Not only is it relevant to interview the patients participating in clinical trials – it can also be highly valuable to…